Meet the Team: A chat with Eric Spierings (University Medical Center Utrecht)
en-GBde-DEes-ESfr-FR

Meet the Team: A chat with Eric Spierings (University Medical Center Utrecht)

06/05/2024 youris.com

Hello, Eric! First, thank you very much for accepting our invitation to this interview.First, could you explain the role of your team in ULISES?
The team of University Medical Center Utrecht takes the lead in epitope optimisation, leveraging computational approaches. Our primary objective is to harness computational methodologies to enhance the immunological disparity between therapeutic targets and the patients’ immune systems.
What type of expertise does your team bring to the project’s research objectives?
Our team offers extensive expertise in Human Leucocyte Antigen (HLA)-derived T- and B-cell epitopes and in alloimmune responses following exposure to foreign HLA molecules. We have developed a patented algorithm tailored for computing HLA-derived epitopes, seamlessly integrated into our computational pipeline to refine the selection of therapeutic targets for subsequent project phases. Our team has a robust track record in epitope matching in the realm of transplantation, with numerous research papers published on the subject.
What does your research focus on?
With regard to the ULISES project objectives, our research focuses on designing an advanced immunological strategy to target cancer cells. Our patented computational models allow us to maximise epitope mismatches between HLA subtypes introduced into cancer cells and those of the patient’s body. That combined with our aforementioned expertise in epitope mapping and immunological compatibility could inform the selection of optimal HLA subtypes for this strategy, enhancing its efficacy and applicability in various ethnic populations.
What is the most innovative aspect of your work?
The most innovative aspect of our work lies in our integration of cutting-edge computational methodologies with immunological research, enabling precise targeting of cancer cells for immune response. By merging computational approaches with immunotherapy, we aim to revolutionise cancer treatment strategies.

Contacts:
Cristina Fillat (project’s coordinator) – IDIBAPS, cfillat@clinic.cat

Communication Officer:
Ilaria Orfino - ICONS ilaria.orfino@icons.it

Project Website: Project - Ulises (ulises-project.eu)
Twitter: @ulises_eu
LinkedIn: ULISES PROJECT
YouTube: ULISES
Attached files
  • spierings.png
06/05/2024 youris.com
Regions: Europe, Belgium
Keywords: Health, Medical, Public Dialogue - health

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
Copyright 2024 by AlphaGalileo Terms Of Use Privacy Statement